Loading organizations...
Loading organizations...
Innovative biopharmaceuticals for cancer and autoimmune disease treatment.
QureBio has raised $45.4M across 2 funding rounds.
QureBio has raised $45.4M in total across 2 funding rounds.
QureBio has raised $45.4M in total across 2 funding rounds.
QureBio's investors include Fan Rongkui, Lihehongxin Venture Capital Partnership, Longmen Capital, Oriza Holdings.
QureBio has raised $45.4M across 2 funding rounds. Most recently, it raised $14.0M Series C in June 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 5, 2025 | $14.0M Series C | Fan Rongkui | |
| Dec 24, 2021 | $31.4M Series B | Lihehongxin Venture Capital Partnership, Longmen Capital, Oriza Holdings |